Your latest cannabis business info from Europe

Your latest cannabis business info from Europe


Cantourage Group SE and Oceanic Releaf join forces in Europe

Cantourage Group SE and Oceanic Releaf join forces in Europe

Oceanic Releaf, a reputable Canadian company involved with the production and sale of premium cannabis products, has partnered with Cantourage Group SE, a European firm that specialises in the development and distribution of medical cannabis. Together, they are developing the European market’s access to medical cannabis originating from Canada’s Atlantic coast.

Who are the both sides?

A prominent Canadian business, Oceanic Releaf produces and sells premium cannabis products. Situated in the rural Burin Peninsula region of Newfoundland and Labrador, the company has a licensed 5,800-square-metre cultivation facility. Available in many Canadian provinces and more than 100 retail locations across the country, Oceanic Releaf’s three private labels—Oceanic Premium Craft, Booty, and Seaweed—reflect the company’s dedication to highlighting the best the province has to offer.

Cantourage is a leading European company that specialises in the production and distribution of medical preparations and medicines based on cannabis. Cantourage, established in 2019 in Berlin by industry pioneers Norman Ruchholtz, Dr. Florian Holzapfel, and Patrick Hoffmann, enables producers worldwide to quickly, easily, and affordably join the expanding European medical cannabis market through its Fast Track Access platform. With a ticker symbol of “HIGH,” the company has been listed on the Frankfurt Stock Exchange since November 11, 2022. It guarantees adherence to the strictest European pharmaceutical quality standards and provides pharmaceutical-grade products in all relevant market categories.

Details of the collaboration

Patients in Europe now have access to Oceanic Releaf’s rare cultivar “Black Cookies” because of their strategic alliance with Cantourage. In the eastern Canadian province of Newfoundland and Labrador, this unique strain originated on the North Atlantic’s natural coastlines. Because of this partnership, pharmacies in Germany can now sell the cannabis product with a prescription.

At its production facility on the Burin Peninsula in eastern Canada, which has a Health Canada licence, Oceanic Releaf has been manufacturing a variety of cannabis products since 2021. These goods go to the market through more than 100 retail locations around the country and we can find them under the tree house labels Oceanic Premium Craft, Booty, and Seaweed. The company also runs nine retail locations across the province of Newfoundland & Labrador.

Comments and future

Taylor Giovannini, Founder and CEO of Oceanic Releaf, expressed his enthusiasm for entering the European market, stating:

“Oceanic Releaf’s entry into the European market brings us back to our roots of medical cannabis. I am very pleased that together with Cantourage, we can now distribute our products in Europe. This will help even more people to benefit from the medical benefits of cannabis.”

Moreover, Cantourage’s CEO, Philip Schetter, stressed the company’s dedication to helping growers enter the European medical cannabis market by using their Fast Track Access technology. Schetter stated:

“In the future, we want to continually expand and diversify our grower portfolio. Oceanic Releaf is an exciting and successful company with unique products.”


CannabizEU: top cannabis topics of 2023

Medical cannabis: Ananda and DJT Plants join forces with Nottingham Trent University


Sustainability and growth in the hemp&cannabis industry: Synbiotic